在多发性骨髓瘤中基于RNA的治疗策略:从分子点到分娩和临床翻译
Maksim V Baranov1, Igor Shalik1, Angela Tsvetkova1
1Translational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia.
International journal of molecular sciences
|January 28, 2026
概括
RNA疗法为治疗多发性骨髓瘤 (MM) 提供了新的希望,这是一个困难的血液癌症. 这些创新治疗方法,包括mRNA疫苗和RNA工程细胞疗法,显示出克服耐药性和改善患者治疗结果的潜力.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 多发性骨髓瘤 (MM) 是一种复杂的血液癌症,具有显著的全球健康影响.
- 目前的治疗方法因瘤异质性,免疫逃避和毒性而面临局限性,需要新的治疗方法.
研究的目的:
- 审查和评估用于调节多发性骨髓瘤的基于RNA的尖端治疗方法.
- 探索RNA技术在克服治疗耐药性和改善耐火性MM的结果方面的潜力.
主要方法:
- 对基于RNA的治疗方法的临床前和临床证据的全面审查.
- 对mRNA疫苗,小干扰RNA (siRNA),反意义寡核酸 (ASO) 和微RNA (miRNA) 模仿剂/抑制剂的分析.
- 探索RNA工程细胞疗法,包括短暂的CAR-T和脂质纳米粒子输送系统.
主要成果:
- 基于RNA的治疗方法在MM的临床前和临床研究中显示出有前途.
- 用RNA工程的细胞疗法显示出有针对性提供和提高疗效的潜力.
- 这些技术为克服MM中普遍存在的抵抗机制提供了途径.
结论:
- RNA技术具有变革性的潜力,可以在多发性骨髓瘤中实现持久缓解.
- 使用基于RNA的方法,可以为耐火性MM开发个性化和更安全的治疗策略.
- RNA疗法可以减少与治疗相关的毒性和成本,改善患者的护理.
相关概念视频
Translation
156.2K
Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
156.2K
Termination of Translation
27.7K
The large ribosomal subunit has several important structures essential to translation. These include the peptidyl transferase center (PTC) - which is the site where the peptide bond is formed - and a large, internal, water-filled tube through which the nascent polypeptide moves. This latter structure is called the Peptide Exit Tunnel, and it begins at the PTC and spans the body of the large ribosomal subunit. During translation, as the nascent polypeptide chain is synthesized, it passes through...
27.7K
RNA Stability
35.7K
Intact DNA strands can be found in fossils, while scientists sometimes struggle to keep RNA intact under laboratory conditions. The structural variations between RNA and DNA underlie the differences in their stability and longevity. Because DNA is double-stranded, it is inherently more stable. The single-stranded structure of RNA is less stable but also more flexible and can form weak internal bonds. Additionally, most RNAs in the cell are relatively short, while DNA can be up to 250 million...
35.7K
RNA Interference
28.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.0K
Initiation of Translation
38.9K
Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
38.9K
RNA Editing
9.9K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.9K


